Related topic: Gleevec, Conjunctival haemorrhage
Review: could Gleevec cause Conjunctival haemorrhage?
Summary: Conjunctival haemorrhage could be caused by Gleevec, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months, also take Vitamin d, and have Chronic myeloid leukaemia.
We study 20,245 people who have side effects while taking Gleevec from FDA and social media. Among them, 83 have Conjunctival haemorrhage. Find out below who they are, when they have Conjunctival haemorrhage and more.
How are my drugs for patients like me? On eHealthMe, you can find the answer by studying 348 million drug outcomes from FDA and social media. Start now >>>
Gleevec (latest outcomes from 20,428 users) has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml).
Conjunctival haemorrhage (bleeding underneath the conjunctiva) (latest reports from 8,626 patients) has been reported by people with onchocerciasis, osteoporosis, high blood pressure, multiple myeloma, depression.
On Apr, 8, 2014: 20,194 people reported to have side effects when taking Gleevec. Among them, 83 people (0.41%) have Conjunctival Haemorrhage. They amount to 0.97% of all the 8,545 people who have Conjunctival Haemorrhage on eHealthMe.
Time on Gleevec when people have Conjunctival haemorrhage * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Conjunctival haemorrhage||20.59%||35.29%||23.53%||0.00%||5.88%||14.71%||0.00% |
Gender of people who have Conjunctival haemorrhage when taking Gleevec * :
|Conjunctival haemorrhage||75.22%||24.78% |
Age of people who have Conjunctival haemorrhage when taking Gleevec * :
|Conjunctival haemorrhage||0.00%||0.00%||0.00%||0.00%||8.99%||15.73%||11.24%||64.04% |
Severity of Conjunctival haemorrhage when taking Gleevec ** :
How people recovered from Conjunctival haemorrhage ** :
Top conditions involved for these people * :
- Chronic myeloid leukaemia (53 people, 63.86%)
- Gastrointestinal stromal tumour (14 people, 16.87%)
- Hypothyroidism (8 people, 9.64%)
- Nausea (6 people, 7.23%)
- Chronic myeloid leukaemia (in remission) (6 people, 7.23%)
Top co-used drugs for these people * :
- Vitamin d (11 people, 13.25%)
- Folic acid (10 people, 12.05%)
- Ambien (9 people, 10.84%)
- Lasix (8 people, 9.64%)
- Atenolol (8 people, 9.64%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
You can also:
On eHealthMe, Gleevec (imatinib mesylate) is often used for chronic myelogenous leukemia (cml). Find out below the conditions Gleevec is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Gleevec used for and how effective is it:
Other drugs that are used to treat the same conditions:
Drugs in real world that are associated with:
Could your condition cause it?
Comments from related studies:
From this study (4 months ago):
Hyperthyroidism was found on five milligrams od tapezole, still have blood mucous diahreea improved slightly after sixteen days on thyroid med. asacol and dezicol can't be tolerated any suggestions?
From this study (7 months ago):
I began Gleevec therapy in 2001 for my CML, with moderate side effects. In January 2008, I began to have ringing in my ears and it has been non-stop since that time. I tested positve for AIED and I cannot help but wonder if the antibodies in my ears that showed a slightly positive AIED was/is caused by the Gleevec therapy.
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Gleevec, Conjunctival haemorrhage
More reviews for: Gleevec, Conjunctival haemorrhage
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.